AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 26185417
Drug: 0.4 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.4 mg/kg weekly
Trial: 17700388
Drug: 0.2 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg/kg every other week
Trial: 17700388
Drug: 0.4 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.4 mg/kg every other week
Trial: 16135896
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg QD
Trial: 16135896
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg BID
Trial: 16135896
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg QD
Trial: 16135896
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg BID
Trial: 11906322
Drug: 1200 mg
RxNorm normalized name: aspirin 1200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1200 mg thioctic acid
Trial: 19124377
Drug: N-acetylcysteine 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine 600 mg
Trial: 2541740
Drug: Converting‐enzyme inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Converting‐enzyme inhibitor (CEI)
Trial: 29551330
Drug: increase moderate
RxNorm normalized name: Incruse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: increase moderate to vigorous physical activity (MVPA) treatment group
Trial: 28070018
Drug: Curcumin (2000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Curcumin (2000 mg/day Longvida®; n=20)
Trial: 12053590
Drug: Montelukast (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast (5 or 10 mg)
Trial: 2156706
Drug: Intravenous urography
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous urography (IVU)
Trial: 9038591
Drug: Exogenous insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Exogenous insulin (50 m-units h-1 kg-1) for 4 hours
Trial: 1000140
Drug: Aversive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aversive therapy
Trial: 25653574
Drug: Edoxaban 15
RxNorm normalized name: edoxaban 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edoxaban 15 mg once daily
Trial: 22699104
Drug: High-dosage CIMT
RxNorm normalized name: hepatitis B surface antigen vaccine
DrugBank: Hepatitis B Vaccine (Recombinant) (DB11627)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dosage CIMT (6 hours/day for 21 days, total 126 hours)
Trial: 22699104
Drug: Moderate-dosage CIMT
RxNorm normalized name: osage orange pollen extract
DrugBank: Maclura pomifera pollen (DB10988)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate-dosage CIMT (3 hours/day for 21 days, total 63 hours)
Trial: 12088951
Drug: Intraoperative small-dose
RxNorm normalized name: Smallpox (Vaccinia) Vaccine, Live
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraoperative small-dose ketamine (0.15 mg/kg followed by 2 microg. kg(‐1). min(‐1))
Trial: 10334526
Drug: Docetaxel 100
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel 100 mg/m2 i.v. every 3 weeks (n=203)
Trial: 10334526
Drug: Mitomycin 12
RxNorm normalized name: Mitomycin
DrugBank: Mitomycin (DB00305)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mitomycin 12 mg/m2 i.v. every 6 weeks plus vinblastine 6 mg/m2 i.v. every 3 weeks (n=189)
Trial: 7604138
Drug: Nicergoline (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicergoline (2 x 30 mg)
Trial: 21993319
Drug: Intravenous urography
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous urography and renal ultrasonography (no CT scan)
Trial: 16239317
Drug: Mild ovarian
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mild ovarian stimulation with GnRH antagonist co-treatment and transfer of one embryo
Trial: 16239317
Drug: Conventional stimulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional stimulation with GnRH agonist long protocol co-treatment and transfer of two embryos
Trial: 21214105
Drug: Amiodarone (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amiodarone (5 mg/kg)
Trial: 9005747
Drug: 10-mg loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-mg loading dose of warfarin
Trial: 9005747
Drug: 5-mg loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-mg loading dose of warfarin
Trial: 27978942
Drug: Recommended NOAC
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recommended NOAC doses
Trial: 22372543
Drug: Combined superficial
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined superficial & deep fractional skin treatment using a 120‐micron, focused CO(2) laser beam
Trial: 22372543
Drug: Combined superficial
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined superficial & deep fractional skin treatment
Trial: 15708690
Drug: Fludrocortisone 0.1
RxNorm normalized name: fludrocortisone 0.1 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fludrocortisone 0.1 mg/day and salt 1 g/day
Trial: 1737735
Drug: Low-dose intranasal
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose intranasal midazolam (0.25 to 0.5 mg)
Trial: 6390057
Drug: Naloxone (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone (10 micrograms/kg to 100 micrograms/kg) + MPSS (30 mg/kg)
Trial: 6390057
Drug: Bolus doses
RxNorm normalized name: SET,INFUSION,BOLUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bolus doses of naloxone (30 micrograms/kg) + continuous infusion (30 micrograms/kg/hr for 1 hour) + MPSS (30 mg/kg)
Trial: 6390057
Drug: Naloxone (bolus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone (bolus and continuous infusion) without MPSS
Trial: 6390057
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose bolus and continuous infusion of naloxone + MPSS
Trial: 27011266
Drug: Oral prednisolone
RxNorm normalized name: prednisolone Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral prednisolone 1 mg/kg/day, tapering by 5 mg/day, for 2 weeks
Trial: 27011266
Drug: Intrapolyp steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrapolyp steroid injection (40 mg/mL triamcinolone, 1 mL) for up to five times with intervals of 1 week
Trial: 21947706
Drug: Rabeprazole 10
RxNorm normalized name: RABEprazole 10 mg oral delayed release tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabeprazole 10 mg daily after EVL
Trial: 21947706
Drug: No antisecretory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No antisecretory treatment
Trial: 19411667
Drug: Phenylephrine at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenylephrine at a rate of 16.6 microg min(‐1) (concentration 1 microg ml(‐1))
Trial: 19411667
Drug: Ephedrine at
RxNorm normalized name: Ephedrine
DrugBank: Ephedrine (DB01364)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ephedrine at a rate of 1.5 mg min(‐1) (concentration 90 microg ml(‐1))
Trial: 16549920
Drug: Leflunomide (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leflunomide (100 mg/day loading dose for 3 days followed by 20 mg/day orally)
Trial: 9930393
Drug: Psychotherapy in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychotherapy in addition to corticosteroid treatment
Trial: 9930393
Drug: Corticosteroid treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid treatment alone (Control)
Trial: 3519731
Drug: Streptokinase therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Streptokinase therapy
Trial: 7850822
Drug: Thrombolytic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombolytic therapy (general)
Trial: 29848776
Drug: DPP-4 inhibitor
RxNorm normalized name: Fibrinolysis inhibitor
DrugBank: Aprotinin (DB06692)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: DPP-4 inhibitor (alogliptin)
Trial: 27272083
Drug: Naftifine cream
RxNorm normalized name: naftifine Topical Cream
DrugBank: Naftifine (DB00735)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Naftifine cream 2%
Trial: 24071565
Drug: Testosterone (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone (0.5 mg single dose)
Trial: 18343652
Drug: Epoetin alfa
RxNorm normalized name: epoetin alfa
DrugBank: Erythropoietin (DB00016)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epoetin alfa (40,000 IU, subcutaneously, once weekly) initiated within 7 days of the start of the first chemotherapy cycle
Trial: 18343652
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy (epoetin alfa when Hb <= 10 g/dL)
Trial: 10701699
Drug: Nevirapine 15
RxNorm normalized name: Nevirapine
DrugBank: Nevirapine (DB00238)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nevirapine 15 mg via short‐term i.v. infusion
Trial: 10701699
Drug: Nevirapine 50
RxNorm normalized name: nevirapine 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nevirapine 50 mg tablet
Trial: 10701699
Drug: Nevirapine oral
RxNorm normalized name: nevirapine Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nevirapine oral reference solution (50 mg/200 mL)
Trial: 10701699
Drug: Nevirapine 200
RxNorm normalized name: nevirapine 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nevirapine 200 mg production‐line tablet
Trial: 10701699
Drug: Nevirapine oral
RxNorm normalized name: nevirapine Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nevirapine oral reference solution (200 mg/200 mL)
Trial: 8634003
Drug: Psychotherapy (cognitive,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychotherapy (cognitive, behavioral, brief psychodynamic, and group therapies)
Trial: 8634003
Drug: Combined psychotherapy-pharmacotherapy
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined psychotherapy-pharmacotherapy regimens
Trial: 1773125
Drug: Permethrin-impregnated bednets
RxNorm normalized name: Permethrin
DrugBank: Permethrin (DB04930)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Permethrin-impregnated bednets (500 mg/m2)
Trial: 1773125
Drug: Blank formulation
RxNorm normalized name: acid black 52
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blank formulation (similar to EC without permethrin)
Trial: 1773125
Drug: Lambda-cyhalothrin (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lambda-cyhalothrin (25 mg/m2)
Trial: 1773125
Drug: Permethrin (5,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Permethrin (5, 50, or 500 mg/m2)
Trial: 6764605
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg SL-76188
Trial: 6764605
Drug: 175 mg
RxNorm normalized name: caffeine 175 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 175 mg SL-76188
Trial: 6764605
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg SL-76188
Trial: 19727679
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg D-amphetamine
Trial: 20589515
Drug: etoricoxib 120
RxNorm normalized name: etoricoxib 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: etoricoxib 120 mg plus diazepam
Trial: 19451213
Drug: Oral estrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral estrogen therapy (ET)
Trial: 10386529
Drug: Lamotrigine (LTG)
RxNorm normalized name: Lamotrigine
DrugBank: Lamotrigine (DB00555)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lamotrigine (LTG) titrated from 100 mg/day over 6 weeks
Trial: 10386529
Drug: Phenytoin (PHT)
RxNorm normalized name: Phenytoin
DrugBank: Phenytoin (DB00252)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Phenytoin (PHT) titrated from 200 mg/day
Trial: 8885910
Drug: 17-beta-estradiol 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17-beta-estradiol 2 mg alone
Trial: 8885910
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy with norethisterone 1 mg
Trial: 6405877
Drug: Intravenous anaesthesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous anaesthesia with spontaneous ventilation
Trial: 6405877
Drug: Intravenous anaesthesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous anaesthesia with controlled ventilation
Trial: 30907301
Drug: Intravenous alteplase
RxNorm normalized name: Alteplase
DrugBank: Alteplase (DB00009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous alteplase (0.9 mg/kg)
Trial: 23000080
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of aerobic exercise and DASH diet for 6 months
Trial: 16364829
Drug: BQ-123 (0.1,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BQ-123 (0.1, 0.2, and 0.3 mg/kg for 1 h)
Trial: 12059866
Drug: Timolol 0.5%
RxNorm normalized name: Timolol 0.5% Ophthalmic Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Timolol 0.5% and Brimonidine 0.2% (concomitant therapy)
Trial: 12059866
Drug: Brimonidine and
RxNorm normalized name: brimonidine and ripasudil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brimonidine and Timolol/Brimonidine (concomitant treatment)
Trial: 8628712
Drug: Broad spectrum
RxNorm normalized name: Broad spectrum penicillin
DrugBank: Octinoxate (DB09496)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Broad spectrum antibiotics
Trial: 1869979
Drug: Dipyridamole infusion
RxNorm normalized name: Dipyridamole
DrugBank: Dipyridamole (DB00975)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dipyridamole infusion alone
Trial: 6139346
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg zetidoline
Trial: 6139346
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg zetidoline
Trial: 6139346
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg haloperidol (positive control)
Trial: 29737150
Drug: Antispasmina col
RxNorm normalized name: Col-118
DrugBank: Col-118 (DB05778)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antispasmina col forte (50 mg papaverine hydrochloride + 10 mg belladonna extract when needed)
Trial: 29737150
Drug: Buscopan (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buscopan (10 mg when needed)
Trial: 22374556
Drug: DL-alpha-lipoic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DL-alpha-lipoic acid (ALA) 300, 600, 900, and 1200 mg/day for 6 months
Trial: 17038827
Drug: Nasal, inactivated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal, inactivated trivalent influenza virus vaccine (7.5, 15, or 30 microg hemagglutinin antigen)
Trial: 17038827
Drug: Nasal, inactivated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal, inactivated trivalent influenza virus vaccine (30 microg hemagglutinin antigen)
Trial: 10486372
Drug: Endoscopic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endoscopic treatment after evaluation with EUS and endoscopy
Trial: 2127723
Drug: Total Parenteral
RxNorm normalized name: TPN - total parenteral nutrition
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total Parenteral Nutrition (TPN) during the immediate postoperative period (Group I)
Trial: 2127723
Drug: Conventional serum
RxNorm normalized name: Serum, horse
DrugBank: Serum, horse (DB14613)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional serum therapy during the immediate postoperative period (Group II)
Trial: 145840
Drug: Apomorphine hydrochloride
RxNorm normalized name: Apomorphine Hydrochloride
DrugBank: Apomorphine (DB00714)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Apomorphine hydrochloride (1 to 4 mg intramuscularly)
Trial: 145840
Drug: Haloperidol (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol (2 mg intramuscularly) or Sulpiride (100 mg intramuscularly) pretreatment
Trial: 30650286
Drug: Conventional hypoglycemic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional hypoglycemic therapy
Trial: 18472356
Drug: Concurrent chemoradiotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent chemoradiotherapy plus adjuvant chemotherapy (CRT)
Trial: 8039526
Drug: Oral antidiabetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral antidiabetic drugs
Trial: 8706291
Drug: Transdermal oestradiol
RxNorm normalized name: estradiol Transdermal System
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal oestradiol patches, 0.05 mg/day
Trial: 8706291
Drug: Subdermal implants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subdermal implants containing 50 mg oestradiol
Trial: 8706291
Drug: Subdermal implants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subdermal implants containing 50 mg oestradiol with 100 mg testosterone
Trial: 1647495
Drug: 8 mg
RxNorm normalized name: alloin 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg sumatriptan
Trial: 1647495
Drug: Sumatriptan (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sumatriptan (6 mg or 8 mg)
Trial: 31242976
Drug: Cisplatin (Arm
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin (Arm A) - 100 mg/m² 3-weekly or 40 mg/m² weekly during radiation
Trial: 31242976
Drug: Cetuximab (Arm
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetuximab (Arm B) - loading dose 400 mg/m² one week before radiation followed by 250 mg/m² weekly during radiation
Trial: 25344383
Drug: Acitretin (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acitretin (30 mg per day)
Trial: 20974089
Drug: Tai Chi
RxNorm normalized name: Ma Chi Xian
DrugBank: Purslane (DB14327)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tai Chi (n=6), attended classes once a week and practiced 10 minutes daily for 15 weeks
Trial: 15807740
Drug: Topical adapalene
RxNorm normalized name: adapalene Topical Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical adapalene gel (0.1%)
Trial: 2952478
Drug: Topical metronidazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical metronidazole gel (0.75%)
Trial: 12911186
Drug: Selective Estrogen
RxNorm normalized name: Selective estrogen receptor modulator
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selective Estrogen Receptor Modulators (SERMs)
Trial: 11091218
Drug: G-CSF (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G-CSF (1 microg/kg and 5 microg/kg)
Trial: 11091218
Drug: Dexamethasone (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (1 mg/kg b.i.d)
Trial: 9248767
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg racemic nicardipine (conventional preparation)
Trial: 9248767
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg racemic nicardipine (conventional preparation)
Trial: 9248767
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg sustained-release nicardipine
Trial: 8287938
Drug: Nebulized amiloride,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulized amiloride, administered four times daily for two six month periods
Trial: 8287938
Drug: Placebo, administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo, administered four times daily for two six month periods
Trial: 3826597
Drug: Indomethacin (rectal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (rectal administration)
Trial: 29872288
Drug: GB 6.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GB 6.25 μg BID
Trial: 28387543
Drug: 4-AP 10
RxNorm normalized name: 4-AP
DrugBank: Dalfampridine (DB06637)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4-AP 10 mg extended release
Trial: 21466389
Drug: Amlodipine/valsartan (Aml/Val)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine/valsartan (Aml/Val) 5/80 mg
Trial: 18543485
Drug: Huanglan Granule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Huanglan Granule (HLG) - one dosage per day, containing milkvetch root, isatis root and basket fern, each 30 g
Trial: 18543485
Drug: Ribavirin -
RxNorm normalized name: Ribavirin
DrugBank: Ribavirin (DB00811)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ribavirin - 0.2 g, three times per day
Trial: 12482764
Drug: Single caffeine
RxNorm normalized name: Caffeine
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Single caffeine dose (6 mg/kg) 60 min before exercise and placebo 45 min into exercise (CP)
Trial: 12482764
Drug: Divided caffeine
RxNorm normalized name: Caffeine
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Divided caffeine dose (3 mg/kg) 60 min before and 45 min into exercise (CC)
Trial: 12482764
Drug: Divided caffeine
RxNorm normalized name: Caffeine
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Divided caffeine dose (3 mg/kg) (CC)
Trial: 12482764
Drug: Single caffeine
RxNorm normalized name: Caffeine
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Single caffeine dose (6 mg/kg) (CP)
Trial: 12482764
Drug: Caffeine doses
RxNorm normalized name: Caffeine
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine doses (CP and CC)
Trial: 18284032
Drug: N-acetyl cysteine
RxNorm normalized name: N-Acetyl Cysteine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N-acetyl cysteine (NAC) 400 mg per day
Trial: 18284032
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E 400 mg per day
Trial: 18284032
Drug: Placebo (calcium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (calcium gluconate 400 mg per day)